Clinical Performance of the Line Immunoassay, Digital Liquid Chip Method, and Chemiluminescent Immunoassay for Detecting Specific Antinuclear Antibodies
Authors:
Open Access
- 18 August 2023
- journal article
- research article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 148 (5) , 566-572
Abstract
Context: Antinuclear antibodies (ANAs) against certain antigens are useful for identifying autoimmune disorders. Although new solid phase–based immunoassays have been developed for evaluating ANAs, the conventional line immunoassay (LIA) is commonly used in clinical practice. Objective: To compare the clinical performance of 2 newly developed methods for detecting specific ANAs with LIA. Design: Six hundred ninety-six serum samples were collected from 559 patients with autoimmune disease (AID) and 137 controls. The samples were screened by using the LIA, digital liquid chip method (DLCM), and chemiluminescent immunoassay (CLIA) for specific ANAs. The agreement across assays and the clinical performance of each assay in diagnosing ANA-associated rheumatic diseases (AARDs) were evaluated. Results: Almost perfect agreement was observed among all assays for anti–centromere protein B (κ = 0.85–0.97), anti–ribosome P (κ = 0.85–0.88), anti–SSA 52 (κ = 0.86–0.89), and anti–SSA 60 (κ = 0.89–0.91); moderate to substantial agreement was detected for the autoantibodies against Sm, Jo-1, ribonucleoprotein, Scl-70, and SSB (κ = 0.55–0.80). LIA exhibited better sensitivity for diagnosing AARDs, while DLCM and CLIA demonstrated higher specificity. In the subset of AIDs, especially systemic lupus erythematosus, antibody positive percentages varied greatly between assays. Conclusions: The 3 assays showed comparable qualitative agreement; however, the standardization of testing for ANAs remains challenging owing to intermanufacturer variations. Moreover, DLCM and CLIA exhibited better specificity in distinguishing non-AID individuals, whereas LIA was more sensitive in diagnosing AARDs.Keywords
This publication has 26 references indexed in Scilit:
- Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseasesNature Reviews Rheumatology, 2020
- Antinuclear Antibody TestsClinics In Laboratory Medicine, 2019
- Evaluation of the LIA-ANA-Profile-17S for the detection of autoantibodies to nuclear antigensClinical Biochemistry, 2018
- The investigation of interferences in immunoassayClinical Biochemistry, 2017
- 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient CohortsArthritis & Rheumatology, 2016
- Significance of Antibodies Against the Native Ribosomal P Protein Complex and Recombinant P0, P1, and P2 Proteins in the Diagnosis of Chinese Patients with Systemic Lupus ErythematosusJournal of Clinical Laboratory Analysis, 2013
- Updated assessment of the prevalence, spectrum and case definition of autoimmune diseaseAutoimmunity Reviews, 2012
- Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseasesJournal of Autoimmunity, 2009
- Autoantibodies in the diagnosis of systemicrheumatic diseasesSeminars in Arthritis and Rheumatism, 1995
- Bias, prevalence and kappaJournal of Clinical Epidemiology, 1993